Financial reports
ARS
2023 FY
Annual report to shareholders
17 Apr 24
10-K
2023 FY
Annual report
18 Mar 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
10 May 23
ARS
2022 FY
Annual report to shareholders
27 Apr 23
10-K
2022 FY
Annual report
8 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
10 Aug 22
10-Q
2022 Q1
Quarterly report
11 May 22
Current reports
8-K
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
18 Mar 24
8-K
Tenaya Therapeutics Announces Pricing of Underwritten Offering
8 Feb 24
8-K
Tenaya Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
8 Nov 23
8-K
Tenaya Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
9 Aug 23
8-K
Departure of Directors or Certain Officers
12 Jun 23
8-K
Tenaya Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
10 May 23
8-K
Amendments to Articles of Incorporation or Bylaws
21 Mar 23
8-K
Regulation FD Disclosure
10 Mar 23
8-K
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
8 Mar 23
8-K
Tenaya Therapeutics Appoints Amy Burroughs to Board of Directors
7 Dec 22
Registration and prospectus
424B5
Prospectus supplement for primary offering
8 Feb 24
S-8
Registration of securities for employees
31 Jan 24
S-8
Registration of securities for employees
8 Mar 23
424B5
Prospectus supplement for primary offering
17 Nov 22
424B5
Prospectus supplement for primary offering
16 Nov 22
424B5
Prospectus supplement for primary offering
17 Aug 22
S-3
Shelf registration
10 Aug 22
S-8
Registration of securities for employees
23 Mar 22
S-8
Registration of securities for employees
30 Jul 21
424B4
Prospectus supplement with pricing info
30 Jul 21
Proxies
DEFA14A
Additional proxy soliciting materials
17 Apr 24
DEF 14A
Definitive proxy
17 Apr 24
DEFA14A
Additional proxy soliciting materials
27 Apr 23
DEF 14A
Definitive proxy
27 Apr 23
PRE 14A
Preliminary proxy
17 Apr 23
DEFA14A
Additional proxy soliciting materials
28 Apr 22
DEF 14A
Definitive proxy
28 Apr 22
Other
EFFECT
Notice of effectiveness
18 Aug 22
CORRESP
Correspondence with SEC
15 Aug 22
UPLOAD
Letter from SEC
12 Aug 22
SEC STAFF
SEC staff action: Order
2 Aug 21
EFFECT
Notice of effectiveness
30 Jul 21
CERT
Certification of approval for exchange listing
27 Jul 21
CORRESP
Correspondence with SEC
27 Jul 21
CORRESP
Correspondence with SEC
27 Jul 21
CORRESP
Correspondence with SEC
26 Jul 21
UPLOAD
Letter from SEC
15 Jul 21
Ownership
4
Timothy Hoey
6 Mar 24
144
Notice of proposed sale of securities
5 Mar 24
4
Timothy Hoey
27 Feb 24
4
Whittemore Tingley
27 Feb 24
4
LEONE D PATTERSON
27 Feb 24
4
Faraz Ali
27 Feb 24
4
Timothy Hoey
21 Feb 24
144
Notice of proposed sale of securities
20 Feb 24
4
Timothy Hoey
16 Feb 24
4
Whittemore Tingley
16 Feb 24